What changed
$NOC — Develops advanced defense and aerospace technology.
🎯 Q1 FY26 | Rev $10B | EPS $6.14 vs $6.06 🟢 | Margin 10.8%
💡 Consensus expects steady defense spending growth, but the market may be underestimating the cash flow drag from large fixed-price development programs (B-21, Sentinel) and the impact of a potential defense budget slowdown. The 1.28% EPS beat is modest and already priced in.
🏢 Business Quality: 7/10 | Valuation: fair
📉 Reward/Risk: Upside 8% to $585 (18x FY26 EPS of $32.50), downside 12% to $475 (15x FY26 EPS). Ratio ~0.67:1.
🔮 Catalyst: Next quarterly earnings (late July 2026): watch for FCF guidance and B-21/Sentinel milestone updates. Failure signal: negative FCF guidance or program delays.
💰 Entry: Current price $540.81 is near the upper end of fair value. Attractive entry below $500 (17x forward EPS).
Also in play: $LMT $GD $RTX $BA $NOC $HON